[Long term follow-up of non-symptomatic HBsAg carriers].
232 asymptomatic HBsAg carriers were controlled between May/1986 and May/1990. The were detected in our blood bank between 1974 and 1976 or during pregnancy or delivery period after 1981. 23 of 232 (10%) became negative during the follow-up, this happening more frequently in carriers after 5 years of follow-up. Only 2 of 209 carriers with HBsAg were HBeAg positive and 1 of these was also DNA-VHB positive. None of the HBeAg negative carriers showed DNA-VHB; only 5 had increased transaminases. 7 were anti-VHC positive, these individuals experiencing more frequent increases in transaminases. The results of this study suggests that the determination of transaminases, viral activity markers, anti-HD, anti-VHC in HBsAg carriers are enough to identify those with hepatic disease.
González
A
A
Sección de Hepatología, Hospital General Universitario Vall d'Hebrón, Universidad Autónoma, Barcelona.
Vargas
V
V
Hernández-Sánchez
J M
JM
Cortina
M
M
Pelegrí
D
D
López-Talavera
J C
JC
Genescá
J
J
Jardí
R
R
Esteban
R
R
Guardia
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D002353:Carrier State / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged
D006514:Hepatitis B Surface Antigens
Seguimiento a largo plazo de portadores asintomáticos de HBsAg.